🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 67% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Softsule(s)(R) Serving Size
Other Combinations Product Type
67% Evidence Coverage

Supplement Facts — Evidence Check

100 IU (333% DV)
📊 4.5× RDA — above typical dose (UL: 1000 mg) 📚 177 studies (Tier A: 3, B: 90)
RDA 15mg This product: 67.0mg UL 1000mg
30 mg
📊 Market median: 100.0mg (283 products) 📚 142 studies (Tier A: 1, B: 64)
This product: 30mg UL 1200mg
📊 Market median: 200.0mg (198 products) 📚 6 studies — no high-quality reviews
This product: 50mg

Other Ingredients

Medium Chain Triglycerides Gelatin Polysorbate 80 Glycerin Sorbitol Beeswax purified Water hydroxylated Lecithin Titanium Dioxide Annatto extract

Label Claims — Verification

All Other
Structure/Function
All Other (98% of products) Structure/Function (87% of products) Nutrient (16% of products)

Target Groups

Adult (18 - 50 Years) Dairy Free

Product Information

📋 Directions for Use

Directions: Take one (1) softsule(R) daily as a dietary supplement or as directed by your healthcare professional. Softsule(R) to be taken with or after a meal.

⚠️ Warnings & Precautions

KEEP OUT OF THE REACH OF CHILDREN.

If you are pregnant or nursing a baby, seek the advice of a health professional before using this product.

THE BOTTLE CAP ON THIS PRODUCT IS SECURED WITH AN IMPRINTED PLASTIC SEAL. DO NOT USE THIS PRODUCT IF SEAL IS CUT, TORN, BROKEN OR MISSING.

Contains soy.

🧪 Formulation Notes

Contains soy.

Free of: milk & milk by-products, egg & egg by-products, fish, shellfish, tree nuts, peanuts/oil, wheat, starch and yeast.

Additional Information

Keep bottle tightly closed. Store between 15(0)-30(0)C (59(0)-86(0)F). Do not refrigerate

MADE IN THE U.S.A.

CoQ10 Pure(R)

HYDROSOLUBLE(TM) LIPOSOLUBLE(TM)

6948seg 180cc R0113

NDC 54023-6948-2

Cellular Energizer Clinically Tested Enhanced Absorption

Product Details

UPC / SKU 0 14654 99105 8
DSLD Entry Date 2015-06-25
Product Type Other Combinations
Form Softgel Capsule
DSLD ID 46303
Data Updated 2026-04-11

Research Evidence

21 Research Sources
52 Avg Quality Score
13 Rct
4 Meta Analysis
2 Systematic Review
2 Clinical Trial
A Alpha-lipoic acid for diabetic peripheral neuropathy
Systematic Review The Cochrane database of systematic reviews 2024
B Efficacy and Safety of the Combination of Palmitoylethanolamide, Superoxide Dismutase, Alpha Lipoic Acid, Vitamins B12, B1, B6, E, Mg, Zn and Nicotinamide for 6 Months in People with Diabetic Neuropathy
Rct Nutrients 2024
B Alpha Lipoic Acid Supplementation and Iron Homeostasis: A Comprehensive Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials
Meta Analysis International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition 2024
B Effectiveness of alpha-lipoic acid in patients with neuropathic pain associated with type I and type II diabetes mellitus: A systematic review and meta-analysis
Meta Analysis Medicine 2023
C The effects of alpha-lipoic acid supplementation on glucose control and lipid profiles among patients with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Metabolism: clinical and experimental 2018
C A systematic review and meta-analysis of α-lipoic acid in the treatment of diabetic peripheral neuropathy
Meta Analysis European journal of endocrinology 2012
C Oral Alpha Lipoic Acid Treatment for Symptomatic Diabetic Peripheral Neuropathy: A Randomized Double-Blinded Placebo-Controlled Study
Rct Endocrine, metabolic & immune disorders drug targets 2020
C A randomized, double-blind, placebo controlled study to evaluate the effect of alpha-lipoic acid on inhibition of ADP-and collagen-induced platelet aggregation ex vivo in diabetic neuropathy patients on gabapentin or pregabalin
Rct Journal of postgraduate medicine 2024
C Ranking Alpha Lipoic Acid and Gamma Linolenic Acid in Terms of Efficacy and Safety in the Management of Adults With Diabetic Peripheral Neuropathy: A Systematic Review and Network Meta-analysis
Systematic Review Canadian journal of diabetes 2024
C Effect analysis of tanshinone IIA sulfonate sodium combined with a-lipoic acid in patients with diabetes peripheral neuropathy.
Rct Pakistan journal of pharmaceutical sciences
View all evidence for Alpha Lipoic Acid →

Compare Similar Products

View all Alpha Lipoic Acid products →